Negative multiparametric magnetic resonance imaging for prostate cancer: further outcome and consequences - Top-Institutions - MDSpire

Negative multiparametric magnetic resonance imaging for prostate cancer: further outcome and consequences

  • By

  • Maximilian Haack

  • Vanessa Miksch

  • Zhe Tian

  • Gregor Duwe

  • Anita Thomas

  • Angelika Borkowetz

  • Kristina Stroh

  • Christian Thomas

  • Axel Haferkamp

  • Thomas Höfner

  • Katharina Boehm

  • November 1, 2022

  • 0 min

Share

Top Institutions in Urology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Urology
    • Radiology
    • Oncology

  • #2

    National Cancer Institute (NCI), NIH
    National Cancer Institute (NCI), NIH

    Bethesda, MD

    Key Differentiators

    • Urology
    • Radiology
    • Cancer Research

  • #3

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Urology
    • Radiology

  • #4

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Urology
    • Radiology

  • #5

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Urology
    • Radiology

Original Source(s)

Negative multiparametric magnetic resonance imaging for prostate cancer: further outcome and consequences

  • by Maximilian Haack, Vanessa Miksch, Zhe Tian, Gregor Duwe, Anita Thomas, Angelika Borkowetz, Kristina Stroh, Christian Thomas, Axel Haferkamp, Thomas Höfner, Katharina Boehm

  • November 1, 2022

Related Content

Multivariate risk prediction tools including MRI for individualized biopsy decision in prostate cancer diagnosis: current status and future directions

Added value of systematic biopsy in men with a clinical suspicion of prostate cancer undergoing biparametric MRI-targeted biopsy: multi-institutional external validation study

Contemporary options and future perspectives: three examples highlighting the challenges in testicular cancer imaging